Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PHAT Phathom Pharmaceuticals

Trading 09-23 14:54:44 EDT

7.12

-0.64

-8.25%

High7.75	Low7.04	Vol483.27K
Open7.73	D1 Closing7.76	Amplitude9.15%
Mkt Cap576.01M	Tradable Cap455.16M	Total Shares80.90M
T/O3.51M	T/O Rate0.76%	Tradable Shares63.93M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":7.12,"timestamp":1790189669258,"preClose":7.76,"halted":0,"volume":483272,"delay":0,"changeRate":-0.08247422680412367,"floatShares":63926354,"shares":80900900,"eps":-1.265918,"marketStatus":"Trading","change":-0.64,"latestTime":"09-23 14:54:44 EDT","open":7.73,"high":7.75,"low":7.04,"amount":3506603.750936,"amplitude":0.091495,"askPrice":7.12,"askSize":500,"bidPrice":7.1,"bidSize":330,"shortable":3,"etf":0,"ttmEps":-1.265918,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790193600000},"marketStatusCode":2,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":7.76,"preHourTrading":{"tag":"盘前","latestPrice":7.71,"preClose":7.76,"latestTime":"09:29 EDT","volume":443,"amount":3434.2299160000002,"timestamp":1790170199999,"change":-0.05,"changeRate":-0.006443,"amplitude":0.045103},"postHourTrading":{"tag":"盘后","latestPrice":7.8479,"preClose":7.76,"latestTime":"19:55 EDT","volume":171092,"amount":1327695.9007,"timestamp":1790121335144,"change":0.0879,"changeRate":0.011327,"amplitude":0.012616},"volumeRatio":0.353053,"impliedVol":0.8394,"impliedVolPercentile":0.2789},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2669021167","title":"H.C. Wainwright Keeps Their Buy Rating on Phathom Pharmaceuticals (PHAT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669021167","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669021167?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:56","pubTimestamp":1790013391,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Caufield from H.C. Wainwright maintained a Buy rating on Phathom Pharmaceuticals, with a price target of $26.00...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-phathom-pharmaceuticals-phat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-phathom-pharmaceuticals-phat-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311945","title":"Phathom Pharmaceuticals Initiated at Market Perform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311945","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311945?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:48","pubTimestamp":1788968880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHAT/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666977580","title":"Leerink Partners Initiates Coverage on Phathom Pharmaceuticals With Market Perform, $10 PT","url":"https://stock-news.laohu8.com/highlight/detail?id=2666977580","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666977580?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:42","pubTimestamp":1788954135,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (PHAT) has an average rating of Buy and mean price target of $23.70, according to analysts polled by FactSet.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666844915","title":"Phathom Pharmaceuticals initiated with a Market Perform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666844915","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666844915?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948617,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Phathom Pharmaceuticals (PHAT) with a Market Perform rating and $10 price target Published first on TheFly – the ulti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-initiated-with-a-market-perform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-initiated-with-a-market-perform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664290856","title":"Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664290856","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664290856?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastroi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354051/0/en/phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660048525","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT) and BioMarin Pharmaceutical (BMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660048525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660048525?lang=en_us&edition=fundamental","pubTime":"2026-08-17 17:01","pubTimestamp":1786957287,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Phathom Pharmaceuticals (PHAT) and BioMarin Pharmace...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-and-biomarin-pharmaceutical-bmrn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","HCSG","PHAT","XBI","BMRN","IE00B19Z3B42.SGD","BK4137","BK4585","BK4139","BK4588","LABU","BK4007","LU0128526141.USD","XLV","IE0002270589.USD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","LU0029874061.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659179202","title":"Phathom Pharmaceuticals’ Earnings Call Signals Profitable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2659179202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659179202?lang=en_us&edition=fundamental","pubTime":"2026-08-16 08:25","pubTimestamp":1786839909,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals, Inc. (($PHAT)) has held its Q2 earnings call. Read on for the main highlights of the call. Phathom Pharmaceuticals’ latest...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-earnings-call-signals-profitable-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/phathom-pharmaceuticals-earnings-call-signals-profitable-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656392923","title":"Phathom Pharmaceuticals (PHAT) Stock Slides Despite Cash Profit Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2656392923","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656392923?lang=en_us&edition=fundamental","pubTime":"2026-08-01 07:28","pubTimestamp":1785540515,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals came into this earnings print with a bruised stock chart, down double digits over the past month and quarter, and it slipped another 3.1% to US$8.75 in the first full trading day after results. The headline, however, is not the share price. The company reported its first quarter of operating profit on a cash basis excluding stock based compensation, on revenue of US$74.3m.\nFor a gastrointestinal focused biotech that has been firmly in loss making territory, that shift...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/phathom-pharmaceuticals-phat-stock-slides-despite-cash-profi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-phat/phathom-pharmaceuticals/news/phathom-pharmaceuticals-phat-stock-slides-despite-cash-profi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","PHAT","BK4585","BK4588","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655281388","title":"Phathom Pharmaceuticals is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2655281388","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655281388?lang=en_us&edition=fundamental","pubTime":"2026-07-31 03:35","pubTimestamp":1785440100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PHAT/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886383","title":"Phathom Pharmaceuticals price target lowered to $22 from $28 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886383?lang=en_us&edition=fundamental","pubTime":"2026-07-31 03:20","pubTimestamp":1785439238,"startTime":"0","endTime":"0","summary":"Needham lowered the firm’s price target on Phathom Pharmaceuticals (PHAT) to $22 from $28 and keeps a Buy rating on the shares. The company reporte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-price-target-lowered-to-22-from-28-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phathom-pharmaceuticals-price-target-lowered-to-22-from-28-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804247","title":"Phathom Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804247","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804247?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:38","pubTimestamp":1785429494,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryPhathom Pharmaceuticals IncPHAT.OQreported a quarterly adjusted loss of 21 cents per share for the quarter e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL8N43W39F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804205","title":"Phathom Pharmaceuticals Down over 19%, on Track for Largest Percent Decrease Since May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804205?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:32","pubTimestamp":1785429120,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals, Inc.  is currently at $9.34, down $2.30 or 19.76%--Would be lowest close since June 1, 2026, when it closed at $9.24--On pace for largest percent decrease since May 1, 2025, when it fell 21.68%--Currently down five of the past six days--Currently down three consecutive days; down 21.84% over this period--Worst three day stretch since the three days ending May 6, 2025, when it fell 28.57%--Down 13.92% month-to-date; on pace for worst month since May 2026, when it fell 14.37%--Down 43.7% year-to-date--Down 82.89% from its all-time closing high of $54.60 on June 8, 2020--Up 9.37% from 52 weeks ago , when it closed at $8.54--Down 48.34% from its 52-week closing high of $18.08 on Jan. 7, 2026--Up 11.86% from its 52-week closing low of $8.35 on Aug. 1, 2025--Traded as low as $8.90; lowest intraday level since June 2, 2026, when it hit $8.78--Down 23.54% at today's intraday low; largest intraday percent decrease since May 1, 2025, when it fell as much as 28.44%All dat","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655987926","title":"Phathom Pharmaceuticals Q2 Revenue Beats on Voquezna Prescription Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2655987926","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655987926?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:18","pubTimestamp":1785410307,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growthOverviewUS biopharma firm's Q2 revenue rose 88% yr/yr, beating analyst expectationsQ2 operating expenses fell 33% yr/yr due to l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nL1N43W0KS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0566484027.USD","CORT","BK4007","IE00B894F039.SGD","BK4585","IE00B19Z9Z06.USD","IE00B19Z9P08.USD","LU0109394709.USD","BK4532","BMED","PHAT","LU1559883803.SGD","LU0320765992.SGD","BK4533","FBT","PBE","LU0889565916.HKD","BK4139","LU0234570918.USD","BK4588","PSCH","BIIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655287645","title":"Phathom Q2 GAAP Net Loss Narrows to $17.6 Million from Year-ago; Revenue Rises 88% to $74.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655287645","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655287645?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:01","pubTimestamp":1785409265,"startTime":"0","endTime":"0","summary":"Phathom Q2 GAAP net loss narrows to $17.6 million from year-ago; revenue rises 88% to $74.3 millionPhathom reported Q2 2026 net revenues of $74.3 million, up 88% from Q2 2025 and 27% from Q1 2026.Net ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL8gRNRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","PHAT","LU0314104364.USD","SG9999014021.USD","SG9999014005.SGD","NDAQ","IE00BKPKM429.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4588","BCDF","SG9999014013.SGD","LU2095319765.USD","BK4585","BK4007","SG9999014039.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655087612","title":"Phathom Pharmaceuticals Q2 Sales $74.300M Beat $72.789M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655087612","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655087612?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:00","pubTimestamp":1785409239,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly sales of $74.300 million which beat the analyst consensus estimate of $72.789 million by 2.08 percent.  This is a 88.09 percent increase over sales of $39.503","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/07/60792413/phathom-pharmaceuticals-q2-sales-74-300m-beat-72-789m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655887635","title":"Phathom Pharmaceuticals Outlook FY Revenue USD 310-325 Million VS. Ibes Estimate USD 332.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655887635","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655887635?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:59","pubTimestamp":1785409141,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXZ7BFFR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655587638","title":"Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655587638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655587638?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:59","pubTimestamp":1785409141,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nPLXZ7BFFR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655871909","title":"Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655871909","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655871909?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:59","pubTimestamp":1785409140,"startTime":"0","endTime":"0","summary":"~1.7 million total VOQUEZNA prescriptions filled to dateRecord Q2 2026 net revenues of $74.3 million, increased 88% vs. Q2 2025 and 27% vs. Q1 2026Q2 operating expenses of $63.1 million, reduced by 33","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/30/3335890/0/en/Phathom-Pharmaceuticals-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429402.USD","LU2041044095.USD","IE00BN0W2W23.USD","LU2089279066.USD","LU0347712357.USD","BK4585","BK4588","LU1543694498.USD","LU2413666426.HKD","LU1165135440.EUR","LU1721428933.USD","NERD","PHAT","BK4567","BK4007","LU2229751404.USD","LU2413666699.HKD","A","PRN","LU2092937221.SGD","IE00BN0W2V16.EUR","LU1721429741.USD","BK4121","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652213837","title":"Phathom Pharma Schedules Second-quarter Earnings Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2652213837","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652213837?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:02","pubTimestamp":1784548962,"startTime":"0","endTime":"0","summary":"Phathom Pharma schedules second-quarter earnings webcastPhathom Pharmaceuticals will report second-quarter 2026 results on July 30, 2026.A business update will accompany the 8:00 a.m. EDT webcast on J","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL6BHVpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","SG9999014039.USD","BK4588","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4112","IE00BN0W2W23.USD","BK4007","LU2095319765.USD","PHAT","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014005.SGD","LU2210150020.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","BCDF","IE00B64PRP62.GBP","BK4585","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652213805","title":"Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652213805","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652213805?lang=en_us&edition=fundamental","pubTime":"2026-07-20 20:00","pubTimestamp":1784548800,"startTime":"0","endTime":"0","summary":"Management to host conference call on Thursday, July 30, 2026, at 8:00 am EDTFLORHAM PARK, N.J., July  20, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical co","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/20/3329653/0/en/Phathom-Pharmaceuticals-to-Report-Second-Quarter-2026-Financial-Results-and-Provide-Business-Update-on-Thursday-July-30-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.049},{"period":"1month","weight":-0.1251},{"period":"3month","weight":-0.2686},{"period":"6month","weight":-0.2808},{"period":"1year","weight":-0.339},{"period":"ytd","weight":-0.5322}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0547},{"period":"6month","weight":0.1989},{"period":"1year","weight":0.1598},{"period":"ytd","weight":0.1341}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.0658},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.119249},{"month":4,"riseRate":0.571429,"avgChangeRate":0.046876},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.041373},{"month":6,"riseRate":0.714286,"avgChangeRate":0.230291},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.006164},{"month":8,"riseRate":0.714286,"avgChangeRate":0.143553},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.030116},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Phathom Pharmaceuticals(PHAT) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}